Navigation Links
Autism Study Finds Significant Benefit with Hyperbaric Treatment
Date:3/25/2009

MELBOURNE, Fla., March 25 /PRNewswire/ -- In a medical world that tells parents of autistic children to "accept" the condition of their child, a new study brings not only hope, but actual help, to these families. Lead physician and researcher, Daniel Rossignol, M.D., treats children with autism. Seeing his patients improve with hyperbaric oxygen treatment led him to conduct the first large scale, double-blind, controlled study to examine its effectiveness. And, the results of this study demonstrate positive improvements.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090325/LA88558)

Hyperbaric therapy traditionally involves inhaling up to 100% oxygen at a pressure greater than 1 atmosphere (atm) in a pressurized chamber. In the first randomized, controlled, double-blind multicenter trial, published in BMC Pediatrics and entitled "Hyperbaric treatment for children with autism: a multicenter, randomized, double-blind, controlled trial." Dr. Rossignol and colleagues, from 6 centers in the USA, studied 62 children, aged 2-7 years, to assess the efficacy of hyperbaric treatment in children with autism.

The research trial concludes that children with autism who received hyperbaric treatment at 1.3 atmospheres and 24% oxygen for 40 hourly sessions had significant improvements in overall functioning, receptive language, social interaction, eye contact, and sensory/cognitive awareness compared to children who received slightly pressurized room air.

The children were randomly assigned to either 40 hours of hyperbaric treatment at 1.3 atm and 24% oxygen (treatment group) or slightly pressurized room air at 1.03 atm and 21% oxygen (non-treatment group). Clinical outcomes were evaluated by three different scales: the Clinical Global Impression (CGI) scale, the Aberrant Behavior Checklist (ABC), and the Autism Treatment Evaluation Checklist (ATEC).

Dr. Rossignol said, "In our study, we observed significant improvements in several core autistic behaviors with the use of hyperbaric therapy at 1.3 atm compared to children receiving near-placebo treatment. These findings confirm what we are seeing in clinical practice--that many children with autism may benefit with the use of this treatment."

Director of the International Hyperbarics Association, Shannon Kenitz, said, "With autism on the rise, it is promising to see a study that has been conducted with the high standards endorsed by the medical community. Having this scientifically controlled and analyzed study that shows the positive effects of hyperbarics is truly what this community has needed. The study not only presents the benefit of Hyperbaric Oxygen Therapy for children with autism, but also gives families the hope that so many other therapies have failed to do."

"The impact of this study on the autism community is significant. It brings validity to a successful intervention that needs to become part of mainstream medicine," commented Kyle Van Dyke, M.D., and Autism Specialist from Madison, Wisconsin.

According to Philip James, M.D., an expert in hyperbaric medicine out of the UK, this study is "An article of outstanding merit and interest in its field."

The growing concern regarding autism in this country is reinforced by the critically high ranking this study as earned by BMC Pediatrics. It is currently the most accessed article and projected to continue to climb in significance.

www.ihausa.org

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Kyle VanDyke

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=87122

Shannon Kenitz

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=87051


'/>"/>
SOURCE International Hyperbarics Association, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Curemark Receives Investigational New Drug Clearance for CM-AT for Autism
2. Autism Website Relaunches to Offer Resources, Treatments and Hope for Families
3. NIH will use $60 million in Recovery Act funds to support strategic autism research
4. April is Autism Awareness Month
5. Heightened level of amygdala activity may cause social deficits in autism
6. Kids Brain Trust: A New Nonprofit Gives Parents Hope of Defeating Autism
7. Autism Speaks Celebrates Second Annual World Autism Awareness Day with an Array of International Events on April 2
8. Watch Me Learn Offers Schools a Teaching Solution for Children with Autism
9. Autism Support Network and the Israeli Society for Autistic Children Form International Alliance
10. Caldwell College to Host National Conference on Autism and Applied Behavior Analysis in April, Autism Awareness Month
11. UCI scientists to study brain region linked to autism, schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... (PRWEB) , ... June 23, 2017 , ... ... plastic surgeon practicing in Newburgh, New York, has recently begun offering three new ... to offering the best cutting-edge procedures and reducing downtime, Dr. Rubinstein is excited ...
(Date:6/23/2017)... ... ... Goodcents Deli Fresh Subs today announced the opening of a new restaurant in ... Kan. 66604 (near 21st and Gage). It is owned and operated by long-time Goodcents ... the Topeka and Bonner Springs, Kan. area. , “Goodcents has such a loyal ...
(Date:6/23/2017)... Georgia (PRWEB) , ... June 23, 2017 , ... ... Negative Breast Cancer Conference from Sept. 18 to 20. , The two-day conference ... (TNBC) subtype with the goal of improving patients’ lives and eliminating racial breast ...
(Date:6/23/2017)... ... June 23, 2017 , ... PureLife Dental is pleased to ... supplier for CDA members. As part of the amalgam separator endorsement, all CDA members ... more than $400 off the retail value. This partnership between PureLife and CDA is ...
(Date:6/23/2017)... CA (PRWEB) , ... June 23, 2017 , ... Ulster ... 26th June, 2017 from 9 am to 3 pm to present to graduate students ... program is an original curriculum project led by The Health Improvement Service of ...
Breaking Medicine News(10 mins):
(Date:6/14/2017)... 2017  ivWatch LLC, a medical device company focused ... therapy, is pleased to announce it was the Bronze ... Supplies and Equipment at the 2017 Medical Design Excellence ... industry. The award was presented by Medical Device and ... in New York during MD&M ...
(Date:6/11/2017)... 2017  Eli Lilly and Company (NYSE: LLY ... studies of galcanezumab, an investigational treatment for the prevention ... several key secondary endpoints for galcanezumab compared to placebo ... (EVOLVE-1, EVOLVE-2 and REGAIN) will be presented today at ... Boston . "The ...
(Date:6/8/2017)... ANGELES , June 8, 2017   Responding to ... drug oversight and the death of singer Chris Cornell ... on Human Rights International offers a free online ... better educate consumers and families about psychotropic drug risks. ... Ledger , who died from an accidental overdose, has called ...
Breaking Medicine Technology: